Jeffrey Balser

Jeffrey Balser

Director/Board Member at CVS HEALTH CORPORATION

Net worth: 2 M $ as of 31/07/2026

64 year
Consumer Services
Commercial Services
Retail Trade

Profile

Jeffrey R.
Balser
is President & Chief Executive Officer at Vanderbilt University Medical Center.
Dr. Balser is Independent Director at CVS Health Corp.
since 2022.
Dr. Balser is Director at Tulane University (Louisiana).
Dr. Balser is Director at Center for Medical Interoperability, Inc. since 2015.
Dr. Balser is Director at Nashville Health Care Council.
Dr. Balser is Member of the National Academy of Sciences since 2009.
Dr. Balser is Dean at Vanderbilt University School of Medicine.
Formerly, Dr. Balser was Independent Director at Varian Medical Systems, Inc. from 2018 to 2021.
Dr. Balser was Director at Medpace Research, Inc. Dr. Balser earned a doctorate from Vanderbilt University.
Dr. Balser completed undergraduate studies at Tulane University (Louisiana).

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
14/05/2026 15,717 ( 0% ) 2 M $ 31/07/2026

Jeffrey Balser active positions

CompaniesPositionStart
CVS HEALTH CORPORATION Director/Board Member 12/09/2022
Director/Board Member 09/04/2015
Chief Executive Officer -
Corporate Officer/Principal 01/01/2009
Corporate Officer/Principal -
Director/Board Member -
Director/Board Member -

Former positions of Jeffrey Balser

CompaniesPositionEnd
VARIAN MEDICAL SYSTEMS, INC. Director/Board Member 15/04/2021
NEPHROGENEX INC Director/Board Member -
See the detail of Jeffrey Balser's experience

Training of Jeffrey Balser

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

65

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Retail Trade

Health Technology

Consumer Services

Consumer Services

Distribution Services

Health Services

Commercial Services

Commercial Services

Consumer Services

Commercial Services

  1. Stock Market
  2. Insiders
  3. Jeffrey Balser